Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02556463
Title A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and Palliative Radiation in Subjects With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | CAN

Facility Status City State Zip Country Details
Research Site San Francisco California 94115 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site Minneapolis Minnesota 55455 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site New York New York 10029 United States Details
Research Site Chapel Hill North Carolina 27599-7305 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Toronto Ontario M5G 1Z6 Canada Details
Research Site Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field